Campion Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Campion Asset Management's LLY Position: Q3 2026 in Review
Campion Asset Management reduced its Eli Lilly (LLY) stake by 2.2% in Q3 2026, selling an estimated $68.4K and leaving 2,625 shares worth $3.04M. The position accounts for 1.89% of the portfolio, ranked #15.
Campion Asset Management first reported a position in LLY in Q1 2021 and has held it in 23 quarters since. The position peaked at $3.22M in Q2 2026. 4,397 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Campion Asset Management held 2,625 shares of Eli Lilly worth $3.04M as of Q3 2026.
- Campion Asset Management sold 58 Eli Lilly shares in Q3 2026, an estimated $68.4K.
- Eli Lilly made up 1.89% of Campion Asset Management's portfolio in Q3 2026, its #15 holding.
- Campion Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 23 quarters since.
- Campion Asset Management's Eli Lilly position peaked at $3.22M in Q2 2026.
- 4,397 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Campion Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.